| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |